A Novel mTOR-Regulated Phosphorylation Site in Elongation Factor 2 Kinase Modulates the Activity of the Kinase and Its Binding to Calmodulin

REFERENCES

• Alessi, D. R. 1997. The protein kinase C inhibitors Ro31-8220 and GF109203X are equally potent inhibitors of MAPKAP kinase-1β and p70 S6 kinase. FEBS Lett. 402:121–123.
   PubMed Web of Science ®Google Scholar
• Alessi, D. R., Kozlowski M. T., Weng Q.-P., Morrice N., and Avruch J.. 1998. 3-Phosphoinositide-dependent protein kinase 1 (PDK1) phosphorylates and activates the p70 S6 kinase in vivo and in vitro. Curr. Biol. 8:69–81.
   PubMed Web of Science ®Google Scholar
• Aoki, M., Blazek E., and Vogt P. K.. 2001. A role for the kinase mTOR in cellular transformation induced by the oncoproteins P3K and Akt. Proc. Natl. Acad. Sci. USA 98:136–141.
   PubMed Web of Science ®Google Scholar
• Avruch, J., Belham C., Weng Q., Hara K., and Yonezawa K.. 2001. The p70 S6 kinase integrates nutrient and growth signals to control translational capacity. Prog. Mol. Subcell. Biol. 26:115–154.
   PubMedGoogle Scholar
• Balendran, A., Hare G. R., Kieloch A., Williams M. R., and Alessi D. R.. 2000. Further evidence that 3-phosphoinositide-dependent protein kinase-1 (PDK1) is required for the stability and phosphorylation of protein kinase C (PKC) isoforms. FEBS Lett. 484:217–223.
   PubMed Web of Science ®Google Scholar
• Beauloye, C., Marsin A. S., Bertrand L., Krause U., Hardie D. G., Vanoverschelde J. L., and Hue L.. 2001. Insulin antagonizes AMP-activated protein kinase activation by ischemia or anoxia in rat hearts, without affecting total adenine nucleotides. FEBS Lett. 505:348–352.
   PubMed Web of Science ®Google Scholar
• Beugnet, A., Tee A. R., Taylor P. M., and Proud C. G.. 2002. Evidence that intracellular amino acids regulate translation factor function in mammalian cells. Biochem. J. 372:555–566.
   Google Scholar
• Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 77:248–254.
   Google Scholar
• Browne, G. J., Finn S. G., and Proud C. G.. 5 January 2004. Stimulation of the AMP-activated protein kinase leads to activation of eukaryotic elongation factor 2 kinase and to its phosphorylation at a novel site, serine 398. J. Biol. Chem. http://www.jbc.org/cgi/reprint/M309773200v1.
   Google Scholar
• Browne, G. J., and Proud C. G.. 2002. Regulation of peptide-chain elongation in mammalian cells. Eur. J. Biochem. 269:5360–5368.
   PubMedGoogle Scholar
• Campbell, L. E., Wang X., and Proud C. G.. 1999. Nutrients differentially modulate multiple translation factors and their control by insulin. Biochem. J. 344:433–441.
   PubMedGoogle Scholar
• Carlberg, U., Nilsson A., and Nygard O.. 1990. Functional properties of phosphorylated elongation factor 2. Eur. J. Biochem. 191:639–645.
   PubMedGoogle Scholar
• Choi, K.-M., McMahon L. P., and Lawrence J. C.. 2003. Two motifs in the translational repressor PHAS-I required for efficient phosphorylation by mammalian target of rapamycin and for recognition by raptor. J. Biol. Chem. 278:19667–19673.
   PubMedGoogle Scholar
• Cohen, P., Alessi D. R., and Cross D. A. E.. 1997. PDK1, one of the missing links in insulin signal transduction? FEBS Lett. 410:3–10.
   PubMed Web of Science ®Google Scholar
• Dennis, P. B., Jaeschke A., Saitoh M., Fowler B., Kozma S. C., and Thomas G.. 2001. Mammalian TOR: a homeostatic ATP sensor. Science 294:1102–1105.
   PubMed Web of Science ®Google Scholar
• Diggle, T. A., Seehra C. K., Hase S., and Redpath N. T.. 1999. Analysis of the domain structure of elongation factor-2 kinase by mutagenesis. FEBS Lett. 457:189–192.
   PubMed Web of Science ®Google Scholar
• Diggle, T. A., Subkhankulova T., Lilley K. S., Shikotra N., Willis A. E., and Redpath N. T.. 2001. Phosphorylation of elongation factor-2 kinase on serine 499 by cAMP-dependent protein kinase induces Ca2+/calmodulin-independent activity. Biochem. J. 353:621–626.
   PubMedGoogle Scholar
• Dutil, E. M., Toker A., and Newton A. C.. 1998. Regulation of conventional protein kinase C isozymes by phosphoinositide-dependent kinase 1 (PDK-1). Curr. Biol. 8:1366–1375.
   PubMed Web of Science ®Google Scholar
• Everett, A. D., Stoops T. D., Nairn A. C., and Brautigan D.. 2001. Angiotensin II regulates phosphorylation of translation elongation factor-2 in cardiac myocytes. Am. J. Physiol. 281:H161–H167.
   Google Scholar
• Fingar, D. C., Salama S., Tsou C., Harlow E., and Blenis J.. 2002. Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. Genes Dev. 16:1472–1487.
   PubMed Web of Science ®Google Scholar
• Gingras, A.-C., Raught B., and Sonenberg N.. 2001. Control of translation by the target of rapamycin proteins. Prog. Mol. Subcell. Biol. 27:143–174.
   PubMedGoogle Scholar
• Hara, K., Yonezawa K., Weng Q.-P., Kozlowski M. T., Belham C., and Avruch J.. 1998. Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF4E BP1 through a common effector mechanism. J. Biol. Chem. 273:14484–14494.
   PubMed Web of Science ®Google Scholar
• Horman, S., Browne G. J., Krause U., Patel J. V., Vertommen D., Bertrand L., Lavoinne A., Hue L., Proud C. G., and Rider M. H.. 2002. Activation of AMP-activated protein kinase leads to the phosphorylation of elongation factor 2 and an inhibition of protein synthesis. Curr. Biol. 12:1419–1423.
   PubMed Web of Science ®Google Scholar
• Jaeschke, A., Hartkamp J., Saitoh M., Roworth W., Nobukuni T., Hodges A., Sampson J., Thomas G., and Lamb R.. 2002. Tuberous sclerosis complex tumor suppressor-mediated S6 kinase inhibition by phosphatidylinositide-3-OH kinase is mTOR independent. J. Cell Biol. 159:217–224.
   PubMedGoogle Scholar
• Knebel, A., Haydon C. E., Morrice N., and Cohen P.. 2002. Stress-induced regulation of eEF2 kinase by SB203580-sensitive and -insensitive pathways. Biochem. J. 367:525–532.
   PubMedGoogle Scholar
• Knebel, A., Morrice N., and Cohen P.. 2001. A novel method to identify protein kinase substrates: eEF2 kinase is phosphorylated and inhibited by SAPK4/p38delta. EMBO J. 20:4360–4369.
   PubMed Web of Science ®Google Scholar
• Le Good, J. A., Ziegler W. H., Parekh D. B., Alessi D. R., Cohen P., and Parker P. J.. 1998. Protein kinase C isotypes controlled by phosphoinositide 3-kinase through the protein kinase PDK1. Science 281:2042–2045.
   PubMed Web of Science ®Google Scholar
• Manning, B. D., and Cantley L. C.. 2003. Rheb fills a GAP between TSC and TOR. Trends Biochem. Sci. 28:573–576.
   PubMed Web of Science ®Google Scholar
• McLeod, L. E., Wang L., and Proud C. G.. 2001. β-Adrenergic agonists increase phosphorylation of elongation factor 2 in cardiomyocytes without eliciting calcium-independent eEF2 kinase activity. FEBS Lett. 489:225–228.
   PubMed Web of Science ®Google Scholar
• McManus, E. J., and Alessi D. R.. 2002. TSC1-TSC2: a complex tale of PKB-mediated S6K regulation. Nat. Cell Biol. 4:E214–E216.
   PubMedGoogle Scholar
• Neshat, M. S., Mellinghoff I. K., Tran C., Stiles B., Thomas G., Petersen R., Frost P., Gibbons J. J., Wu H., and Sawyers C. L.. 2001. Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR. Proc. Natl. Acad. Sci. USA 98:10314–10319.
   PubMed Web of Science ®Google Scholar
• Nojima, H., Tokunaga C., Eguchi S., Oshiro N., Hidayat S., Yoshino K., Hara K., Tanaka J., Avruch J., and Yonezawa K.. 2003. The mTOR partner, raptor, binds the mTOR substrates, p70 S6 kinase and 4E-BP1, through their TOS (TOR signaling) motifs. J. Biol. Chem. 278:15461–15464.
   PubMed Web of Science ®Google Scholar
• Parekh, D., Ziegler W., Yonezawa K., Hara K., and Parker P. J.. 1999. Mammalian TOR controls one of two kinase pathways acting upon PKCdelta and epsilon. J. Biol. Chem. 274:34758–34764.
   PubMed Web of Science ®Google Scholar
• Pavur, K. S., Petrov A. N., and Ryazanov A. G.. 2000. Mapping the functional domains of elongation factor-2 kinase. Biochemistry 39:12216–12224.
   PubMed Web of Science ®Google Scholar
• Pearson, R. B., Dennis P. B., Han J. W., Williamson N. A., Kozma S. C., Wettenhall R. E. H., and Thomas G.. 1995. The principal target of rapamycin-induced p70S6k inactivation is a novel phosphorylation site within a conserved hydrophobic domain. EMBO J. 14:5279–5287.
   PubMedGoogle Scholar
• Price, N. T., Nakielny S. F., Clark S. J., and Proud C. G.. 1989. The two forms of the beta-subunit of initiation factor-2 from reticulocyte lysates arise from proteolytic degradation. Biochim. Biophys. Acta 1008:177–182.
   PubMedGoogle Scholar
• Proud, C. G. 2002. Regulation of mammalian translation factors by nutrients. Eur. J. Biochem. 269:5338–5349.
   PubMedGoogle Scholar
• Pullen, N., Dennis P. B., Andjelkovic M., Dufner A., Kozma S. C., Hemmings B. A., and Thomas G.. 1998. Phosphorylation and activation of p70S6k by PDK1. Science 279:707–710.
   PubMed Web of Science ®Google Scholar
• Ravikumar, B., Stewart A., Kita H., Kato K., Duden R., and Rubinsztein D. C.. 2003. Raised intracellular glucose concentrations reduce aggregation and cell death caused by mutant huntingtin exon 1 by decreasing mTOR phosphorylation and inducing autophagy. Hum. Mol. Genet. 12:985–994.
   PubMed Web of Science ®Google Scholar
• Redpath, N. T., Foulstone E. J., and Proud C. G.. 1996. Regulation of translation elongation factor-2 by insulin via a rapamycin-sensitive signalling pathway. EMBO J. 15:2291–2297.
   PubMedGoogle Scholar
• Ryazanov, A. G., Ward M. D., Mendola C. E., Pavur K. S., Dorovkov M. V., Wiedmann M., Erdjument-Bromage H., Tempst P., Parmer T. G., Prostko C. R., Germino F. J., and Hait W. N.. 1997. Identification of a new class of protein kinases represented by eukaryotic elongation factor-2 kinase. Proc. Natl. Acad. Sci. USA 94:4884–4889.
   PubMed Web of Science ®Google Scholar
• Schalm, S. S., and Blenis J.. 2002. Identification of a conserved motif required for mTOR signaling. Curr. Biol. 12:632–639.
   PubMed Web of Science ®Google Scholar
• Schalm, S. S., Fingar D. C., Sabatini D. M., and Blenis J.. 2003. TOS motif-mediated raptor binding regulates 4E-BP1 multisite phosphorylation and function. Curr. Biol. 13:797–806.
   PubMed Web of Science ®Google Scholar
• Shima, H., Pende M., Chen Y., Fumagalli S., Thomas G., and Kozma S. C.. 1998. Disruption of the p70S6k/p85S6k gene reveals a small mouse phenotype and a new functional S6 kinase. EMBO J. 17:6649–6659.
   PubMed Web of Science ®Google Scholar
• Takano, A., Usui I., Haruta T., Kawahara J., Uno T., Iwata M., and Kobayashi M.. 2001. Mammalian target of rapamycin pathway regulates insulin signaling via subcellular redistribution of insulin receptors substrate 1 and integrates nutritional signals and metabolic signals of insulin. Mol. Cell. Biol. 21:5050–5062.
   PubMed Web of Science ®Google Scholar
• Vanhaesebroeck, B., and Alessi D. R.. 2000. The P13K-PDK1 connection: more than just a road to PKB. Biochem. J. 346:561–576.
   PubMed Web of Science ®Google Scholar
• Wang, L., and Proud C. G.. 2002. Regulation of the phosphorylation of elongation factor 2 by MEK-dependent signalling in adult rat cardiomyocytes. FEBS Lett. 531:285–289.
   PubMed Web of Science ®Google Scholar
• Wang, L., Wang X., and Proud C. G.. 2000. Activation of mRNA translation by insulin in rat cardiomyocytes involves multiple rapamycin-sensitive steps. Am. J. Physiol. 278:H1056–H1068.
   PubMed Web of Science ®Google Scholar
• Wang, X., Campbell L. E., Miller C. M., and Proud C. G.. 1998. Amino acid availability regulates p70 S6 kinase and multiple translation factors. Biochem. J. 334:261–267.
   PubMed Web of Science ®Google Scholar
• Wang, X., Li W., Williams M., Terada N., Alessi D. R., and Proud C. G.. 2001. Regulation of elongation factor 2 kinase by p90RSK1 and p70 S6 kinase. EMBO J. 20:4370–4379.
   PubMed Web of Science ®Google Scholar
• Williams, M. R., Arthur J. S. C., Balendran A., van der Kaay J., Poli V., Cohen P., and Alessi D. R.. 2000. Role of PDK1 in mediating the activation of AGC kinases in embryonic stem cells defined by targeted disruption of the PDK1 gene. Curr. Biol. 20:439–448.
   Google Scholar
• Zhang, H., Cicchetti G., Onda H., Koon H. B., Asrican K., Bajraszewski N., Vazquez F., Carpenter C. L., and Kwiatkowski D. J.. 2003. Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR. J. Clin. Investig. 112:1223–1233.
   PubMed Web of Science ®Google Scholar